159 related articles for article (PubMed ID: 35382757)
1. Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012-2017.
Jiang M; Wang X; Zhu L; Yang YH; Yao KH; Dong F; Shi W; Wang Q; Song WQ; Liu G
BMC Infect Dis; 2022 Apr; 22(1):338. PubMed ID: 35382757
[TBL] [Abstract][Full Text] [Related]
2. Serotype distribution, antibiotic resistance pattern, and multilocus sequence types of invasive Streptococcus pneumoniae isolates in two tertiary pediatric hospitals in Beijing prior to PCV13 availability.
Shi W; Li J; Dong F; Qian S; Liu G; Xu B; Zhou L; Xu W; Meng Q; Wang Q; Shen K; Ma L; Yao K
Expert Rev Vaccines; 2019 Jan; 18(1):89-94. PubMed ID: 30526145
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
5. The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.
Gaviria-Agudelo CL; Jordan-Villegas A; Garcia C; McCracken GH
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):253-259. PubMed ID: 26907814
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
7. Early clinical predictors for the prognosis of invasive pneumococcal disease.
Wu S; Guo X; Xu Z; Han M; Huang L; Tao Y; Li Y; Li Y; Zhang T; Bai Z
BMC Infect Dis; 2020 Sep; 20(1):651. PubMed ID: 32887563
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China.
Xu Y; Wang Q; Yao K; Dong F; Song W; Liu G; Xu B; Shi W; Li Y; Li K; Liu Y; Qian S
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1833-1842. PubMed ID: 33786728
[TBL] [Abstract][Full Text] [Related]
9. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
Charfi F; Smaoui H; Kechrid A
Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
[TBL] [Abstract][Full Text] [Related]
10. [A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].
Kara SS; Polat M; Tapisiz A; Nar Otgun S; Tezer H
Mikrobiyol Bul; 2014 Apr; 48(2):346-50. PubMed ID: 24819273
[TBL] [Abstract][Full Text] [Related]
11. Invasive pneumococcal disease in Indian adults: 11 years' experience.
Jayaraman R; Varghese R; Kumar JL; Neeravi A; Shanmugasundaram D; Ralph R; Thomas K; Veeraraghavan B
J Microbiol Immunol Infect; 2019 Oct; 52(5):736-742. PubMed ID: 29884448
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era.
Izquierdo C; Ciruela P; Hernández S; García-García JJ; Esteva C; Moraga-Llop F; Díaz-Conradi A; Martínez-Osorio J; Solé-Ribalta A; de Sevilla MF; González-Peris S; Codina G; Planes AM; Uriona S; Campins M; Muñoz-Almagro C; Salleras L; Domínguez A
Epidemiol Infect; 2020 Nov; 148():e279. PubMed ID: 33148361
[TBL] [Abstract][Full Text] [Related]
13. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.
González-Díaz A; Càmara J; Ercibengoa M; Cercenado E; Larrosa N; Quesada MD; Fontanals D; Cubero M; Marimón JM; Yuste J; Ardanuy C
Clin Microbiol Infect; 2020 Jun; 26(6):753-759. PubMed ID: 31756452
[TBL] [Abstract][Full Text] [Related]
14. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.
Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M
Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246
[TBL] [Abstract][Full Text] [Related]
15. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.
Riva E; Salvini F; Garlaschi ML; Radaelli G; Giovannini M
BMC Infect Dis; 2012 May; 12():106. PubMed ID: 22554011
[TBL] [Abstract][Full Text] [Related]
16. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
17. Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia.
Al-Sheikh YA; K Gowda L; Mohammed Ali MM; John J; Khaled Homoud Mohammed D; Chikkabidare Shashidhar P
Ann Lab Med; 2014 May; 34(3):210-5. PubMed ID: 24790908
[TBL] [Abstract][Full Text] [Related]
18. Population genetic structure, serotype distribution and antibiotic resistance of
Gagetti P; Lo SW; Hawkins PA; Gladstone RA; Regueira M; Faccone D; Sireva-Argentina Group ; Klugman KP; Breiman RF; McGee L; Bentley SD; Corso A
Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34586054
[TBL] [Abstract][Full Text] [Related]
19. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan.
Lee HY; Wu TL; Su LH; Li HC; Janapatla RP; Chen CL; Chiu CH
J Microbiol Immunol Infect; 2018 Aug; 51(4):500-509. PubMed ID: 28690025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
